It is a pharma private limited company based in Delhi, Delhi, India, established in 2018.
2018 | Delhi, Delhi, India | ActiveVentas Pharmaceuticals Private Limited, a active private limited company, was established on 13 March 2018 in Delhi, Delhi, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U74999DL2018PTC330780. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.20 M and a paid-up capital of ₹0.20 M.
Its leadership includes Gautam Kumar (Director), Umesh Kumar (Director), Rajiv Kumar (Director). Past directors included Kamod Kumar Gupta. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at H. No. 523, First Floor, Block-Aw Sanjay Gandhi Transport Nagar, Delhi, Delhi, 110042.
U74999DL2018PTC330780
330780
13 March 2018
₹0.20 M
₹0.20 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Ventas Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Gautam Kumar | Director | 13 Mar 2018 | Current |
| Umesh Kumar | Director | 13 Mar 2018 | Current |
| Rajiv Kumar | Director | 13 Mar 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 25 Feb 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Ventas Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 23.56% decrease. The company also saw a substantial fall in profitability, with a 53.98% decrease in profit. The company's net worth observed a substantial decline by a decrease of 40.42%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Ventas Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Ventas Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Ventas Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ventas Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Ventas Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Ventas Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
Gautam Kumar was appointed as a Director was appointed as a Director on 13 Mar 2018 & has been associated with this company since 7 years 9 months . was recorded as a recent event.
Umesh Kumar was appointed as a Director was appointed as a Director on 13 Mar 2018 & has been associated with this company since 7 years 9 months . was recorded as a recent event.
Rajiv Kumar was appointed as a Director was appointed as a Director on 13 Mar 2018 & has been associated with this company since 7 years 9 months . was recorded as a recent event.
The activity Ventas Pharmaceuticals Private Limited was registered on 13 Mar 2018 with Roc Delhi & aged 7 years 9 months as per MCA records. was completed.
The CIN of Ventas Pharmaceuticals Private Limited is U74999DL2018PTC330780.
Ventas Pharmaceuticals Private Limited is headquartered at H. No. 523, First Floor, Block-Aw Sanjay Gandhi Transport Nagar, Delhi, Delhi, 110042.
Ventas Pharmaceuticals Private Limited was incorporated on 13 March 2018.
The current directors of Ventas Pharmaceuticals Private Limited are
The primary industry of Ventas Pharmaceuticals Private Limited is Trade.
Ventas Pharmaceuticals Private Limited is unlisted.
The authorized capital of Ventas Pharmaceuticals Private Limited is ₹0.20 M, and the paid-up capital is ₹0.20 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX